• News
  • SAN DIEGO
  • Finance

Isis Pharma shares rise on Kynamro approval

Shares of Isis Pharmaceuticals Inc. soared Wednesday on news that the U.S. Food and Drug Administration approved its new drug application for its Kynamro cholesterol drug.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISIS
31.62
  1.46  
+ 4.84%
1,489,263,000
62.66
22.25

Insider Trade Data

Date Insider Shares Type Value
07/02/2014 Geary, Richard S 164 Sell $5,896
07/01/2014 Crooke, Stanley T 17,500 Exchange $247,465
07/01/2014 O, Neil Patrick R 1,500 Sell $53,000
07/01/2014 O, Neil Patrick R 1,500 Exchange $15,435
07/01/2014 Crooke, Stanley T 17,500 Sell $622,559

Isis Pharmaceuticals Inc. Executive(s):

Stanley Crooke

  • Chief Executive Officer, Founder, President, Chairman

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing
SIC - 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Subscribe Today!